A detailed history of Nisa Investment Advisors, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,351 shares of OVID stock, worth $1,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,351
Previous 400 487.75%
Holding current value
$1,293
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$0.26 - $0.35 $507 - $682
1,951 Added 487.75%
2,351 $0
Q1 2025

Apr 30, 2025

SELL
$0.31 - $0.96 $518 - $1,606
-1,673 Reduced 80.7%
400 $0
Q4 2024

Jan 17, 2025

BUY
$0.93 - $1.36 $1,627 - $2,380
1,750 Added 541.8%
2,073 $1,000
Q3 2024

Oct 24, 2024

BUY
$0.75 - $1.3 $135 - $234
180 Added 125.87%
323 $0
Q2 2024

Jul 19, 2024

BUY
$0.7 - $3.34 $100 - $477
143 New
143 $0

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $38.7M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.